Advertisement
U.S. markets open in 4 hours 59 minutes

Isofol Medical AB (publ) (ISOFOL.ST)

Stockholm - Stockholm Real Time Price. Currency in SEK
3.00000.0000 (0.00%)
As of 10:30AM CET. Market open.
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
0
721
12,797
22,407
37,119
Operating Expense
43,635
42,405
180,340
226,872
223,614
Operating Income
-43,635
-41,684
-167,543
-204,465
-186,495
Net Non Operating Interest Income Expense
4,323
4,573
147
-163
-149
Pretax Income
-39,270
-37,071
-159,793
-200,251
-188,991
Tax Provision
0
0
0
0
1
Net Income Common Stockholders
-39,270
-37,071
-159,793
-200,251
-188,992
Diluted NI Available to Com Stockholders
-39,270
-37,071
-159,793
-200,251
-188,992
Basic EPS
-0.33
-0.23
-0.99
-1.59
-3.07
Diluted EPS
-0.33
-0.23
-0.99
-1.59
-3.07
Basic Average Shares
161,515
161,515
161,515
125,645
61,469
Diluted Average Shares
161,515
161,515
161,515
125,645
61,469
Total Operating Income as Reported
-43,633
-41,683
-167,543
-204,465
-186,494
Total Expenses
43,635
42,405
180,340
226,872
223,614
Net Income from Continuing & Discontinued Operation
-39,270
-37,071
-159,793
-200,251
-188,992
Normalized Income
-39,270
-37,071
-163,605
-203,786
-186,978
Interest Income
4,323
4,573
147
5
4
Interest Expense
0
0
0
168
153
Net Interest Income
4,323
4,573
147
-163
-149
EBIT
-39,270
-37,071
-159,793
-200,083
-188,838
EBITDA
-39,266
-37,034
-159,726
-198,487
-187,068
Reconciled Depreciation
4
37
67
1,596
1,770
Net Income from Continuing Operation Net Minority Interest
-39,270
-37,071
-159,793
-200,251
-188,992
Total Unusual Items Excluding Goodwill
0
0
3,812
3,535
-2,014
Total Unusual Items
0
0
3,812
3,535
-2,014
Normalized EBITDA
-39,266
-37,034
-163,538
-202,022
-185,054
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0